Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist

Journal of Medicinal Chemistry

Volumn 41, Issue 18, 1998, Pages 3360-3366

  Calo', Girolamo ^a   Guerrini, Remo ^a   Bigoni, Raffaella ^a   Rizzi, Anna ^a   Bianchi, Clementina ^a   Regoli, Domenico ^a   Salvadori, Severo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NOCICEPTIN; TETRAPEPTIDE;

AMINO TERMINAL SEQUENCE; ANALGESIA; ARTICLE; DRUG EFFECT; DRUG PURIFICATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; NEUROTRANSMITTER RELEASE; STRUCTURE ACTIVITY RELATION;

ANIMALS; MALE; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, OPIOID; STRUCTURE-ACTIVITY RELATIONSHIP; VAS DEFERENS;

EID: 0032572820     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970805q     Document Type: Article

References (46)

1. Abbreviations follow IUPAC-IUB Joint Commission on Biochemical Nomenclature for amino acids and peptides: J. Biol. Chem. 1985, 260, 1442. Additional abbreviations used herein are as follows: Ava (5-aminovaleric acid), β-Ala (3-aminopropionic acid), Boc (tert-butoxycarbonyl), DIPCDI (1,3-diisopropylcarbodiimide), Fmoc [(9-fluorenylmethyl)oxycarbonyl], Fmoc-PAL-PEG-PS [5-(4'-Fmoc-aminomethyl-3′,5′-dimethoxyphenoxy)-valeric acid] on the poly(ethylene glycol)/polystyrene support), Gaba (4-aminobutyric acid), HOBt (1-hydroxybenzotriazole), MALDI-TOF (Matrix Assisted Laser Desorption Ionization Time-of-Flight), OBzl (benzyl ester), PITC (phenylisothiocyanate), Pmc (2,2,5,7,8-pentamethylchroman-6-sulfonyl), tBu (tert-butyl), TEA (triethylamine), TFA (trifluoroacetic acid), Trt (trityl), WSC (1-ethyl-3-(3′ dimethylaminopropyl)carbodiimide·HCl).
2. Meunier, J. C.; Mollereau, C.; Toll, L.; Suaudeau, C.; Moisand, C.; Alvinerie, P.; Butour, J. L.; Guillemot, J. C.; Ferrara, P.; Monserrat, B.; Mazarguil, H.; Vassart, G.; Parmentier, M.; Costentin, J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 377, 532-535.
3. Reinscheid, R. K.; Nothacker, H. P.; Bourson, A.; Ardati, A.; Henningsen, R. A.; Bunzow, J. R.; Grandy, D. K.; Langen, H.; Monsma, F. J., Jr.; Civelli, O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270, 792-794.
4. Dooley, C. T.; Houghten, R. A. Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci. 1996, 59, 23-29.
5. Calo', G.; Rizzi, A.; Bodin, M.; Neugebauer, W.; Salvadori, S.; Guerrini, R.; Bianchi, C.; Regoli, D. Pharmacological characterization of nociceptin receptor: an in vitro study. Can. J. Physiol. Pharmacol. 1997, 75, 713-718.
6. Berzetei-Gurske, I. P.; Schwartz, R. W.; Toll, L. Determination of activity for nociceptin in the mouse vas deferens. Eur. J. Pharmacol. 1996, 302, R1-R2.
7. Giuliani, S.; Maggi, C. A. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br. J. Pharmacol. 1996, 118, 1567-1569.
8. Giuliani, S.; Maggi, C. A. Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea-pig left atrium. Eur. J. Pharmacol. 1997, 332, 231-236.
9. Calo', G.; Rizzi, A.; Bogoni, G.; Neugebauer, V.; Salvadori, S.; Guerrini, R.; Bianchi, C.; Regoli, D. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur. J. Pharmacol. 1996, 311, R3-R5.
10. Patel, H. J.; Giembycz, M. A.; Spicuzza, L.; Barnes, P. J.; Belvisi, M. G. Naloxone-insensitive inhibition of acetylcholine release from parasympatethic nerves innervating guinea-pig trachea by the novel opioid, nociceptin. Br. J. Pharmacol. 1997, 120, 735-736.
11. Helyes, Z.; Nemeth, J.; Pinter, E.; Szolcsanyi, J. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br. J. Pharmacol. 1997, 121, 613-615.
12. Giuliani, S.; Tramontana, M.; Lecci, A.; Maggi, C. A. Effect of nociceptin on heart rate and blood pressure in anaesthetized rats. Eur. J. Pharmacol. 1997, 333, 177-179.
13. Champion, H. C.; Kadowitz, P. J. Nociceptin, an endogenous ligand for the ORL(1) receptor, has novel hypotensive activity in the rat. Life Sci. 1997, 60, PL241-PL245.
14. Kapusta, D. R.; Sezen, S. F.; Chang, J. K.; Lippton, H.; Kenigs, V. A. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci. 1996, 60, PL15-PL21.
15. Mogil, J. S.; Grisel, J. E.; Reinsheid, R. K.; Civelli, O.; Belknap, J. K.; Grandy, D. K. Orphainin FQ is a functional anti-opioid peptide. Neuroscience 1996, 75, 333-337.
16. Stanfa, L. C.; Chapman, V.; Kerr, N.; Dickenson, A. H. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo. Br. J. Pharmacol 1996, 118, 1875-1877.
17. Xu, X. J.; Hao, J. X.; Wiesenfeld-Hllin, Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/ nociceptin in the rat. NeuroReport 1996, 7, 2092-2094.
18. Sandin, J.; Georgieva, J.; Schott, P. A.; Ogren, S. O.; Terenius, L. Nociceptin/Orphanin FQ microinjected into hippocampus impairs spatial learnig in rats. Eur. J. Neurosci. 1997, 9, 194-197.
19. Pomonis, J. D.; Billington, C. J.; Levine, A. S. Orphanin FQ, agonist of orphan opioid receptor RORL1, stimulates feeding in rats. NeuroReport 1996, 8, 369-371.
20. Stratford, T. R.; Holahan, M. R.; Kelley A. E. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. NeuroReport 1997, 8, 423-426.
21. + evoked glutamate release from rat cerebrocortical slices. Br. J. Pharmacol. 1996, 119, 1081-1083.
22. Neal, M. J.; Cunningham, J. R.; Paterson, S. J.; McKnight, A. T. Inhibition by nociceptin of the light-evoked release of ACh from retinal cholinergic neurones. Br. J. Pharmacol. 1997, 120, 1399-1400.
23. Murphy, N. P.; Ly, H. T.; Maidment, N. T. Intracerebroventricular orphanin FQ nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience 1996, 75, 1-4.
24. Montiel, J. L.; Cornille, F.; Roques, B. P.; Noble, F. Nociceptin/ orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J. Neurochem. 1997, 68, 354-361.
25. Noble, F.; Roques, B. P. Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice. FEBS Lett. 1997, 401, 227-229.
26. Guerrini, R.; Calo', G.; Rizzi, A.; Bianchi, C.; Lazarus, L. H.; Salvadori, S.; Temussi, P. A.; Regoli, D. Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin(1-13) amide. J. Med. Chem. 1997, 40, 1789-1793.
27. Fehrentz, J. A.; Castro, B. An efficient synthesis of optically active α-(tert-butoxycarbonylamino)-aldehydes from α-amino acids. Synthesis 1983, 676-678.
28. 2NH) bond isosteres. Pep. Res. 1993, 6, 10-12.
29. King, D. S.; Fields, C. G.; Fields, G. B. A cleavage method which minimizes side reactions following Fmoc solid-phase peptide synthesis. Int. J. Pept. Protein Res. 1990, 36, 255-266.
30. Schiller, P. W.; Nguyen, T. M. D.; Lemieux, C. New types of opioid peptide analogs showing high μ-receptor selectivity and preference for either central or peripheral sites. In Peptides 1988; Jung, G., Bayer, E. Eds.; Berlin: Walter de Gruyter, 1988, pp 613-615.
31. Zadina, J. E.; Hackler, L.; Ge, L. J.; Kastin, A. J. A potent and selective endogenous agonist for the μ opiate receptor. Nature 1997, 386, 499-502.
32. Broccardo, M.; Erspamer, V.; Falconieri Erspamer, G.; Improta, G.; Linari, G.; Melchiorri, P.; Montecucchi, P. C. Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin. Br. J. Pharmacol. 1981, 73, 625-631.
33. Erspamer, V.; Melchiorri, P.; Falconieri Erspamer G.; Negri, L.; Corsi, R.; Severini, G.; Barra, D.; Simmaco, M.; Kreil, G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5188-5192.
34. 2): a potent and specific agonist for morphine (μ) receptors. Science 1981, 212, 75-77.
35. Morley, J. S. Structure-activity relationship of enkephalin-like peptides. Annu. Rev. Pharmacol. Toxicol. 1980, 20, 81-110.
36. Hruby, V. J.; Gehrig, C. A. Recent developments in the design of receptor specific opioid peptides. Med. Res. Rev. 1989, 9, 343-401.
37. Reinscheid, R. K.; Ardati, A.; Monsma, F. J. Civelli, O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J. Biol. Chem. 1996, 271, 14163-14168.
38. Meyer, J. P.; Davis, P.; Lee, K. B.; Porreca, F.; Yamamura, H. I.; Hruby, V. J. Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A. J. Med. Chem. 1995, 38, 3462-3468.
39. Guerrini, R.; Calo', G.; Rizzi, A.; Bigoni, R.; Bianchi, C.; Salvadori, S.; Regoli, D. A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol. 1998, 123, 163-165.
40. Kobayashi, T.; Ikeda, K.; Togashi, S.; Itoh, N.; Kumanishi, T. Effects of sigma ligands on the nociceptin/orphanin FQ receptor coexpressed with the G-protein-activated K+ channel in Xenopus oocytes. Br. J. Pharmacol. 1997, 120, 986-987.
41. Dooley, C. T.; Spaeth, C. G.; Berzetei-Gurske, I. P.; Craymer, K.; Adapa, I. D.; Brandt, S. R.; Houghten, R. A.; Toll, L. Binding and in vitro activities of peptides with high affinity for the Nociceptin/Orphanin FQ receptor, ORL1. J. Pharmacol. Exp. Ther. 1997, 283, 735-41.
42. Carpino, A. L.; Han, G. Y. The 9-fluorenylmethoxycarbonyl amino-protecting group. J. Org. Chem. 1972, 37, 3404-3409.
43. Hughes, J.; Kosterlitz, H. W.; Leslie, F. M. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Br. J. Pharmacol. 1975, 53, 371-381.
44. Tallarida, R. J.; Murray, R. B. Manual of pharmacologic calculations with computer programs. New York: Springer-Verlag, 1987.
45. Vanhoutte, P. M.; Humphrey, P. P. A.; Spedding, M. X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol. Rev. 1996, 48, 1-2.
46. Jenkinson, D. H.; Barnard, E. A.; Hoyer, D.; Humphrey, P. P. A.; Leff, P.; Shankley, N. P. International Union of Pharmacology Commitee on receptor nomenclature and drug classification. XI. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev. 1995, 47, 255-266.